Here’s What Bristol-Myers Squibb Will Look Like After Acquiring Celgene

Submitted by admin on January 4, 2019 - 9:14am

Source:

Yahoo/Motley Fool

News Tags:

M&A

Celgene

Bristol-Myers Squibb

Headline:

Here’s What Bristol-Myers Squibb Will Look Like After Acquiring Celgene

snippet:

Bristol-Myers Squibb (NYSE: BMY) is acquiring Celgene (NASDAQ: CELG)for roughly $74 billion to create a biopharma goliath. The combined company will boast eight billion-dollar blockbuster drugs and an envy-inspiring product pipeline. Here's what Bristol-Myers Squibb will look like after its Celgene acquisition closes.

Search form

You are here

Here’s What Bristol-Myers Squibb Will Look Like After Acquiring Celgene

Here’s What Bristol-Myers Squibb Will Look Like After Acquiring Celgene